A 2017 review summarised neuroprotective properties of silymarin in animal models, including: Reduction of amyloidogenic activity (relevant in Alzheimer's research) Anti-inflammatory action in nerve tissue Reduction of oxidative stress in the brain Possible positive effects on cognitive function Possible reduction of stroke risk Whether these effects can be achieved in humans at attainable concentrations of silymarin in particular whether sufficient quantities can cross the blood-brain barrier remains unclear
Plos ONE 7 , e52570 (2012)
All peptide protocols are monitored with regular check-ins and lab work
This whole-person approach can help stall or soften the impacts of the hormonal cascade
[ CrossRef ] [ Google scholar ] [ PubMed ] Milanovic M, Fan DNY, Belenki D, Dbritz JHM, Zhao Z, Yu Y, et al
More critically, this masking, although neither complete nor permanent, can permit neurologic dysfunction to develop and sometimes become irreversible